Coeptis Therapeutics Holdings Inc - Warrants — Financial Statements (NASDAQ:COEPW)

Financials

Total revenue ——000 501 K Gross profit ——000 365.53 K Operating expenses 68.43 K681.32 K34.2 M21.49 M10.05 M 13.58 M Selling/general/admin expenses ——34.18 M3.96 M945.64 K 1.46 M Research & development ——20.89 K6.67 M2.33 M 1.31 M Operating income 68.43 K-681.32 K-34.2 M-21.49 M-10.05 M -13.22 M Non-Operating Income, Total —71-3.38 M224.59 K-822.92 K -448.62 K Interest expense, net of interest capitalized ——218.41 K107.69 K396.12 K 280.52 K Non-Operating Income, excl. Interest Expenses —0-3.6 M337.38 K-1.37 M -659.94 K Unusual income/expense —71—-220.48 K152.11 K -69.19 K Pretax income 68.43 K-681.25 K-37.57 M-21.27 M-10.88 M -13.67 M Equity in earnings ————— — Taxes ——000 0 Non-controlling/minority interest ————1.06 M 2.29 M After tax other income/expense ————— — Net income before discontinued operations 67.23 K15.23 M-37.57 M-21.27 M-10.88 M -13.67 M Discontinued operations ————— — Net income 67.23 K15.23 M-37.57 M-21.27 M-10.88 M -13.67 M Dilution adjustment —0——— — Preferred dividends —6.68 M——— — Diluted net income available to common stockholders 67.23 K8.55 M-37.57 M-21.27 M-10.88 M -13.67 M Basic earnings per share (Basic EPS) —32.4-52.6-16.6-5.65 -8.3 Diluted earnings per share (Diluted EPS) —40.61-52.6-16.6-5.65 -8.3 Average basic shares outstanding —375 K714.78 K1.28 M1.92 M 13.45 M Diluted shares outstanding —375 K714.78 K1.28 M1.92 M 13.45 M EBITDA ——-33.19 M-20.49 M-9.05 M -12.08 M EBIT ——-34.2 M-21.49 M-10.05 M -13.22 M Cost of revenue ——000 135.47 K Other cost of goods sold ————— — Depreciation & amortization (cash flow) ——1 M1 M1 M 1.14 M